{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:39:40Z","timestamp":1790699980439,"version":"4.1.0"},"reference-count":363,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-tongshu2021\/ms-0162"],"award-info":[{"award-number":["Y-tongshu2021\/ms-0162"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-MSDZD2022-0760"],"award-info":[{"award-number":["Y-MSDZD2022-0760"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202206010117"],"award-info":[{"award-number":["202206010117"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173036"],"award-info":[{"award-number":["82173036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472902"],"award-info":[{"award-number":["82472902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFC3602904"],"award-info":[{"award-number":["2022YFC3602904"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032268","name":"Sixth Affiliated Hospital of Guangzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1212060013"],"award-info":[{"award-number":["2023B1212060013"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","award":["2023B1111030006"],"award-info":[{"award-number":["2023B1111030006"]}],"id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbcan.2026.189586","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:19:29Z","timestamp":1775575169000},"page":"189586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics"],"prefix":"10.1016","volume":"1881","author":[{"given":"Shanhe","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zean","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189586_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2026.189586_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2026.189586_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.annonc.2020.02.002","article-title":"Epigenetic modulations and lineage plasticity in advanced prostate cancer","volume":"31","author":"Ge","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0025","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1172\/JCI76412","article-title":"Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer","volume":"124","author":"Qin","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41585-019-0237-8","article-title":"Towards precision oncology in advanced prostate cancer","volume":"16","author":"Ku","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25325-9","article-title":"MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer","volume":"12","author":"Kalogirou","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0040","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","article-title":"The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1","volume":"5","author":"Romero","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112912","article-title":"Chemo-immunotherapy: A new trend in cancer treatment","volume":"15","author":"Sordo-Bahamonde","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0060","article-title":"Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach","volume":"4","author":"Sridaran","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","article-title":"How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer","volume":"24","author":"Stultz","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bbcan.2026.189586_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the tumor inflammation signature (TIS): results from the cancer genome atlas (TCGA)","volume":"6","author":"Danaher","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0080","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2019.02965","article-title":"The intriguing history of cancer immunotherapy","volume":"10","author":"Dobosz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0085","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb0090","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41422-018-0089-4","article-title":"Elimination of CD4(low)HLA-G(+) t cells overcomes castration-resistance in prostate cancer therapy","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0095","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0105","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052569","article-title":"Immunotherapy in advanced prostate Cancer-Light at the end of the tunnel?","volume":"23","author":"von Amsberg","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","article-title":"Loss and revival of androgen receptor signaling in advanced prostate cancer","volume":"40","author":"Formaggio","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189586_bb0125","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2019.01835","article-title":"The dark side of fibroblasts: Cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment","volume":"10","author":"Monteran","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2019.00603","article-title":"The tumor immune contexture of prostate cancer","volume":"10","author":"Vitkin","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","article-title":"Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications","volume":"10","author":"Pu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153985","article-title":"Optimisation of sample preparation from primary mouse tissue to maintain RNA integrity for methods examining translational control","volume":"15","author":"Munro","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41585-023-00795-2","article-title":"The potential role of the microbiota in prostate cancer pathogenesis and treatment","volume":"20","author":"Pernigoni","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0155","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cac2.12316","article-title":"The theory of tumor ecosystem","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0165","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.aan1295","article-title":"A new cancer ecosystem","volume":"355","author":"Horning","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb0170","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.18632\/oncotarget.3430","article-title":"Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype","volume":"6","author":"Amend","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189586_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01105-2","article-title":"Applications of single-cell sequencing in cancer research: Progress and perspectives","volume":"14","author":"Lei","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0195","article-title":"Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-022-01280-w","article-title":"Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis","volume":"15","author":"Han","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells12151970","article-title":"A review of single-cell RNA-Seq annotation, integration, and cell-cell communication","volume":"12","author":"Cheng","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189586_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41698-024-00667-x","article-title":"Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis","volume":"8","author":"Cheng","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0215","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030995","article-title":"Spatial transcriptomics in human cardiac tissue","volume":"26","author":"Nguyen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2023.110671","article-title":"Spatial transcriptomics: technologies, applications and experimental considerations","volume":"115","author":"Wang","year":"2023","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2026.189586_bb0240","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1038\/s41596-024-01001-2","article-title":"A versatile tissue-rolling technique for spatial-omics analyses of the entire murine gastrointestinal tract","volume":"19","author":"Monasterio","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbcan.2026.189586_bb0245","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00432-024-05816-0","article-title":"Spatial transcriptomics in cancer research and potential clinical impact: a narrative review","volume":"150","author":"Cilento","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0255","article-title":"Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer","volume":"3","author":"De Vargas Roditi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb0260","article-title":"Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression","author":"Zhao","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbcan.2026.189586_bb0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13619-024-00206-w","article-title":"Application and new findings of scRNA-seq and ST-seq in prostate cancer","volume":"13","author":"Li","year":"2024","journal-title":"Cell Regen."},{"key":"10.1016\/j.bbcan.2026.189586_bb0270","first-page":"21","article-title":"The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy","volume":"11","author":"Feng","year":"2024","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0275","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41420-021-00752-1","article-title":"Sympathetic signaling facilitates progression of neuroendocrine prostate cancer","volume":"7","author":"Dwivedi","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0280","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0285","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1038\/s41467-024-45332-w","article-title":"The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids","volume":"15","author":"Lachance","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0290","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","article-title":"Evolution of myeloid-mediated immunotherapy resistance in prostate cancer","volume":"637","author":"Lyu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0295","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2024.03.011","article-title":"Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8(+) t cells","volume":"187","author":"Cao","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0300","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41556-025-01673-2","article-title":"Lactate dehydrogenase b facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8(+) t cells","volume":"27","author":"Wan","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0305","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41467-022-33780-1","article-title":"Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease","volume":"13","author":"Wong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0310","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1038\/s41467-025-62381-x","article-title":"AR(+)TREM2(+) macrophage induced pathogenic immunosuppression promotes prostate cancer progression","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0315","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41698-025-01152-9","article-title":"TREM2-mediated regulation of myeloid cells in the tumor microenvironment: new insights and therapeutic prospects","volume":"9","author":"Huang","year":"2025","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0320","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0325","doi-asserted-by":"crossref","DOI":"10.1080\/13685538.2023.2183947","article-title":"Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer","volume":"26","author":"Wu","year":"2023","journal-title":"Aging Male"},{"key":"10.1016\/j.bbcan.2026.189586_bb0330","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1038\/s41467-025-58740-3","article-title":"Targeting site-specific n-glycosylated B7H3 induces potent antitumor immunity","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0335","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40164-023-00407-0","article-title":"ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer","volume":"12","author":"Xin","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00262-024-03633-5","article-title":"Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning","volume":"73","author":"Kang","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189586_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060751","article-title":"Immune checkpoint inhibitor therapy for prostate cancer: present and future prospectives","volume":"15","author":"Rai","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189586_bb0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12032-022-01719-7","article-title":"Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes","volume":"39","author":"Chen","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020418","article-title":"Epithelial-mesenchymal transition: a fundamental cellular and microenvironmental process in benign and malignant prostate pathologies","volume":"12","author":"Goncharov","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2026.189586_bb0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41568-025-00873-0","article-title":"Identification, functional insights and therapeutic targeting of EMT tumour states","volume":"26","author":"Dong","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0365","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","article-title":"Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer","volume":"41","author":"Hawley","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0370","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ccell.2024.06.015","article-title":"Tumor-infiltrating lymphocytes: a new hope","volume":"42","author":"Sarnaik","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12071113","article-title":"Quantifying spatial heterogeneity of tumor-infiltrating lymphocytes to predict survival of individual cancer patients","volume":"12","author":"Suwalska","year":"2022","journal-title":"J.Pers. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305724","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/path.5757","article-title":"Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory t cells and macrophages as adverse prognostic factors","volume":"255","author":"Andersen","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0395","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41698-024-00540-x","article-title":"Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk","volume":"8","author":"Rasmussen","year":"2024","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8(+) t cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0405","first-page":"143","article-title":"Bystander t cells in cancer immunology and therapy","volume":"3","author":"Meier","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189586_bb0410","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41423-025-01373-9","article-title":"Cis- and trans-binding chimeric costimulatory receptors enhance t-cell fitness and tumor control","volume":"23","author":"Hern\u00e1ndez-L\u00f3pez","year":"2026","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0415","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/pros.23890","article-title":"Increased infiltration of CCR4-positive regulatory t cells in prostate cancer tissue is associated with a poor prognosis","volume":"79","author":"Watanabe","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.bbcan.2026.189586_bb0420","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/modpathol.2012.164","article-title":"CD4 helper T cells, CD8 cytotoxic t cells, and FOXP3(+) regulatory t cells with respect to lethal prostate cancer","volume":"26","author":"Davidsson","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0425","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pros.24524","article-title":"Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile","volume":"83","author":"Adorno Febles","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.bbcan.2026.189586_bb0430","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7150\/thno.105423","article-title":"B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189586_bb0435","doi-asserted-by":"crossref","first-page":"61425","DOI":"10.18632\/oncotarget.18251","article-title":"Expression of LAG-3 defines exhaustion of intratumoral PD-1(+) T cells and correlates with poor outcome in follicular lymphoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189586_bb0440","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.21037\/tau-2025-414","article-title":"Immunotherapy research for prostate cancer from 2000 to 2024: a bibliometric and visualization analysis","volume":"14","author":"Li","year":"2025","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0445","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010851","article-title":"Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer","volume":"13","author":"Lassoued","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010020","article-title":"Myeloid-derived suppressor cells in prostate cancer: present knowledge and future perspectives","volume":"11","author":"Koinis","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189586_bb0455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0460","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1372771","article-title":"Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer","volume":"15","author":"Kobayashi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0470","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cjp2.160","article-title":"Polymorphonuclear MDSCs are enriched in the stroma and expanded in metastases of prostate cancer","volume":"6","author":"Wen","year":"2020","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117002","article-title":"Macrophage dynamics in prostate cancer: molecular to therapeutic insights","volume":"177","author":"Gu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2026.189586_bb0480","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies","volume":"44","author":"Nasir","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0485","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0490","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1541-7786.MCR-20-0740","article-title":"The prognostic potential of human prostate Cancer-associated macrophage subtypes as revealed by single-cell transcriptomics","volume":"19","author":"Siefert","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0495","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1158\/2326-6066.CIR-24-0591","article-title":"Inhibition of PIM kinase in tumor-associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy","volume":"13","author":"Clements","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15694","article-title":"Single-cell RNA sequencing uncovers heterogeneous transcriptional signatures in tumor-infiltrated dendritic cells in prostate cancer","volume":"9","author":"Feriz","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbcan.2026.189586_bb0505","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.7150\/thno.111096","article-title":"Targeting neutrophil extracellular traps in cancer progression and metastasis","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189586_bb0510","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0515","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12894-024-01685-4","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a meta-analysis","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18010151","article-title":"Targeting cancer-associated fibroblasts in prostate cancer: recent advances and therapeutic opportunities","volume":"18","author":"Chen","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0525","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","article-title":"Neutrophil diversity and function in health and disease","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s11658-024-00591-9","article-title":"The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management","volume":"29","author":"Ullah","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbcan.2026.189586_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16162797","article-title":"Targeting IL-8 and its receptors in prostate cancer: inflammation, stress response, and treatment resistance","volume":"16","author":"McClelland","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0540","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12935-025-03941-5","article-title":"Research progress on the mechanisms of CSF3R mutations in leukemogenesis and treatment strategies","volume":"25","author":"Wang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189586_bb0545","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189586_bb0550","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-15-2463","article-title":"Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs)","volume":"22","author":"Alfaro","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/biom15121696","article-title":"The role of extracellular proteases and extracellular matrix remodeling in the pre-metastatic niche","volume":"15","author":"Okura","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2026.189586_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213441","article-title":"Overcoming immune evasion in the prostate tumor microenvironment: novel targeted strategies to improve treatment outcomes","volume":"17","author":"Huang","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0565","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41391-021-00413-5","article-title":"The microbiome and prostate cancer","volume":"25","author":"Javier-DesLoges","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bbcan.2026.189586_bb0570","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12864-019-5457-z","article-title":"Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer","volume":"20","author":"Feng","year":"2019","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbcan.2026.189586_bb0575","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5347(05)67987-6","article-title":"Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction","volume":"163","author":"Hochreiter","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0580","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pros.20680","article-title":"A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms","volume":"68","author":"Sfanos","year":"2008","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189586_bb0585","article-title":"Characterisation of microbial communities within aggressive prostate cancer tissues","volume":"12","author":"Yow","year":"2017","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0590","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.eururo.2017.03.029","article-title":"The microbiome of the prostate tumor microenvironment","volume":"72","author":"Cavarretta","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0595","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/14796694.2.2.225","article-title":"Links between propionibacterium acnes and prostate cancer","volume":"2","author":"Shannon","year":"2006","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0600","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/pros.22648","article-title":"A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of propionibacterium acnes","volume":"73","author":"Shinohara","year":"2013","journal-title":"Prostate"},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2026.189586_bb0605","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdv.15043","article-title":"Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates","volume":"32","author":"Dr\u00e9no","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0610","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cmi.2016.52","article-title":"Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins","volume":"14","author":"Zhuang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0615","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","article-title":"High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma","volume":"170","author":"Samanta","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/0-387-32957-9_1","article-title":"Polyomaviruses and human diseases","volume":"577","author":"Ahsan","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0625","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1128\/JVI.02461-07","article-title":"BK virus as a cofactor in the etiology of prostate cancer in its early stages","volume":"82","author":"Das","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0630","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pros.22562","article-title":"Human papillomavirus and Epstein Barr virus in prostate cancer: koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer","volume":"73","author":"Whitaker","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.bbcan.2026.189586_bb0635","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pros.10157","article-title":"Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections","volume":"53","author":"Zambrano","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.bbcan.2026.189586_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008736","article-title":"Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men\u2019s Health Study","volume":"5","author":"Cheng","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189586_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030212","article-title":"Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens","volume":"8","author":"Miyake","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189586_bb0650","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/carcin\/bgz008","article-title":"Microbiome signatures in prostate cancer","volume":"40","author":"Banerjee","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189586_bb0655","article-title":"Decoding the tumor-associated microbiota: from origins to nanomedicine applications in cancer therapy","volume":"14","author":"Wang","year":"2025","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0660","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-024-03004-z","article-title":"Cross-reactive CD8(+) t cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)","volume":"43","author":"Cavalluzzo","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0665","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","article-title":"Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies","volume":"5","author":"Cervantes-Villagrana","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0670","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41420-025-02616-4","article-title":"Defining the cellular and molecular features of nerve-invaded cancer cells using a newly characterized experimental model","volume":"11","author":"Joseph","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0675","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-025-02396-6","article-title":"Hijacking homeostasis: the brain-body neural circuitry in tumor pathogenesis and emerging therapeutic frontiers","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0680","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cimb46020062","article-title":"Nerve growth factor and the role of inflammation in tumor development","volume":"46","author":"Ferraguti","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0685","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1038\/s41598-025-87492-9","article-title":"Sympathetic innervation induced by nerve growth factor promotes malignant transformation in gastric cancer","volume":"15","author":"Itami","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189586_bb0690","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41422-024-00946-z","article-title":"Multiple cancer cell types release LIF and gal3 to hijack neural signals","volume":"34","author":"Xu","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063246","article-title":"Pathophysiological roles of actin-binding scaffold protein, ezrin","volume":"23","author":"Kawaguchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0700","article-title":"Ezrin phosphorylation at t567 modulates cell migration, mechanical properties, and cytoskeletal organization","volume":"21","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0705","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","article-title":"The \u03b2(1)-adrenergic receptor links sympathetic nerves to Tcell exhaustion","volume":"622","author":"Globig","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0710","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","article-title":"Nociceptor neurons affect cancer immunosurveillance","volume":"611","author":"Balood","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0715","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1172\/JCI129502","article-title":"\u03922 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells","volume":"129","author":"Mohammadpour","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb0720","first-page":"73","article-title":"Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies","volume":"12","author":"Liu","year":"2025","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0725","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1574884714666181203095437","article-title":"Role of muscarinic acetylcholine receptors in breast cancer: design of metronomic chemotherapy","volume":"14","author":"Sales","year":"2019","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0730","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.15537\/1658-3175.4794","article-title":"Variation of m3 muscarinic receptor expression in different prostate tissues and its significance","volume":"30","author":"Song","year":"2009","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.bbcan.2026.189586_bb0735","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3892\/or.2017.5935","article-title":"\u03917 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2\/STAT3 signaling pathway","volume":"38","author":"Fei","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189586_bb0740","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-019-1616-z","article-title":"The spinal microglial IL-10\/\u03b2-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of \u03b17-nicotinic acetylcholine receptors","volume":"17","author":"Apryani","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbcan.2026.189586_bb0745","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nm.1976","article-title":"Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain","volume":"15","author":"Schweizerhof","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010596","article-title":"Blocking muscarinic receptor 3 attenuates tumor growth and decreases immunosuppressive and cholinergic markers in an orthotopic mouse model of colorectal cancer","volume":"24","author":"Kuol","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0755","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","article-title":"Turning cold tumors into hot tumors to ignite immunotherapy","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0760","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41467-024-49824-7","article-title":"The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer","volume":"15","author":"Hou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0765","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrc.2016.38","article-title":"Mechanisms of cancer dissemination along nerves","volume":"16","author":"Amit","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0770","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","article-title":"Progenitors from the central nervous system drive neurogenesis in cancer","volume":"569","author":"Mauffrey","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0775","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1038\/s41467-023-40314-w","article-title":"Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment","volume":"14","author":"Xue","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/cells14171398","article-title":"Cancer-associated fibroblasts in solid tumors and sarcomas: heterogeneity, function, and therapeutic implications","volume":"14","author":"Badran","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189586_bb0785","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","article-title":"Targeting the peripheral neural-tumour microenvironment for cancer therapy","volume":"23","author":"Yaniv","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0790","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-025-10241-x","article-title":"Sympathetic nerve signaling rewires the tumor microenvironment: a shift in \u201cmicroenvironmental-ity\u201d","volume":"44","author":"Sattler","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189586_bb0795","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canep.2014.03.011","article-title":"Beta-blocker usage and prostate cancer survival: a nested case-control study in the UK clinical practice research datalink cohort","volume":"38","author":"Cardwell","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0800","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2147\/OTT.S78836","article-title":"Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients","volume":"8","author":"Lu","year":"2015","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0805","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-025-06262-2","article-title":"Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers","volume":"151","author":"O\u2019Logbon","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0810","article-title":"Neural-tumor crosstalk and molecular targeting: mechanisms and therapeutic implications in cancer neuroscience","volume":"49","author":"Hou","year":"2026","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bbcan.2026.189586_bb0815","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/1535-7163.MCT-13-0797","article-title":"Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling","volume":"13","author":"Li","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189586_bb0820","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1541-7786.MCR-22-0250","article-title":"Subtype and site specific-induced metabolic vulnerabilities in prostate cancer","volume":"21","author":"Mossa","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb0825","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00432-022-04371-w","article-title":"Metabolic changes during prostate cancer development and progression","volume":"149","author":"Beier","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0830","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26189132","article-title":"Reprogrammed lipid metabolism-associated therapeutic vulnerabilities in prostate cancer","volume":"26","author":"Parupathi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0835","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168649","article-title":"Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs","volume":"134","author":"Han","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb0840","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/ERC-15-0556","article-title":"Androgen control of lipid metabolism in prostate cancer: novel insights and future applications","volume":"23","author":"Butler","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0845","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0850","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-025-02415-x","article-title":"Ferroptosis: CD8(+)T cells\u2019 blade to destroy tumor cells or poison for self-destruction","volume":"11","author":"Liang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0855","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1074\/jbc.M116.766238","article-title":"T cells encountering myeloid cells programmed for amino acid-dependent immunosuppression use Rictor\/mTORC2 protein for proliferative checkpoint decisions","volume":"292","author":"Van de Velde","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189586_bb0860","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189586_bb0865","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","article-title":"Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity","volume":"7","author":"Miret","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217680","article-title":"The arginine metabolism and its deprivation in cancer therapy","volume":"620","author":"Feng","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189586_bb0875","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy - challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0880","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41421-025-00817-w","article-title":"AR to GR switch modulates differential TDO2-Kyn-AhR signalling to promote the survival and recurrence of treatment-induced dormant cells in prostate cancer","volume":"11","author":"Li","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb0885","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","article-title":"IDO and kynurenine metabolites in peripheral and CNS disorders","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0890","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41423-025-01290-x","article-title":"Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumors","volume":"22","author":"Manchon","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094460","article-title":"Altered metabolism in glioblastoma: myeloid-derived suppressor cell (MDSC) fitness and tumor-infiltrating lymphocyte (TIL) dysfunction","volume":"22","author":"Di Ianni","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0900","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189586_bb0905","article-title":"Combined blockade of lipid uptake and synthesis by CD36 inhibitor and SCD1 siRNA is beneficial for the treatment of refractory prostate cancer","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb0910","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) t cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0915","article-title":"Reactive sulfur species as emerging immunomodulators: mechanistic insights and therapeutic prospects","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0920","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1594419","article-title":"ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0925","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166647","article-title":"RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F\/ACSL4 axis","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb0930","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2502423122","article-title":"Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancer","volume":"122","author":"Sushentsev","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189586_bb0935","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/path.6405","article-title":"Spatial profiling of ANO7 in prostate tissue: links to AR-signalling-associated lipid metabolism and inflammation","volume":"265","author":"Mets\u00e4l\u00e4","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0940","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8(+) t cells to drive t cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0945","article-title":"Terminally exhausted CD8(+) T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0950","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ccell.2025.12.001","article-title":"Epitranscriptomic control of cancer hallmarks: functions, mechanisms, and therapeutics of RNA modifications","volume":"44","author":"Deng","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb0955","doi-asserted-by":"crossref","first-page":"28709","DOI":"10.1038\/s41598-025-14639-z","article-title":"Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer","volume":"15","author":"Castagnoli","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189586_bb0960","doi-asserted-by":"crossref","first-page":"15547","DOI":"10.1074\/jbc.M113.473298","article-title":"Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages","volume":"288","author":"Kuda","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189586_bb0965","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00011.2023","article-title":"CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease","volume":"104","author":"Glatz","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2026.189586_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106232","article-title":"HIF-1\u03b1 and nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer","volume":"147","author":"Parveen","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0975","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1530\/ERC-14-0541","article-title":"Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms","volume":"22","author":"Centenera","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb0980","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbi.2010.07.248","article-title":"Stimulation of \u03b2\u2082-adrenergic receptors inhibits calcineurin activity in CD4(+) t cells via PKA-AKAP interaction","volume":"25","author":"Riether","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbcan.2026.189586_bb0985","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of g-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb0990","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/ATVBAHA.111.226837","article-title":"Regulation of lymphocyte function by adenosine","volume":"32","author":"Linden","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb0995","doi-asserted-by":"crossref","first-page":"20135","DOI":"10.1074\/jbc.RA119.009093","article-title":"Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments","volume":"294","author":"Contreras-Baeza","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2026.189586_bb1000","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1697428","article-title":"Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114884","article-title":"Macrophage MCT4 inhibition activates reparative genes and protects from atherosclerosis by histone h3 lysine 18 lactylation","volume":"43","author":"Zhang","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189586_bb1010","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1097\/CM9.0000000000003916","article-title":"Lipid droplets in the tumor microenvironment: biogenesis, functional diversity, and therapeutic targeting","volume":"138","author":"Zhong","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbcan.2026.189586_bb1015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1745168","article-title":"TAM plasticity under androgen deprivation therapy and PARP inhibition in prostate cancer: a multi-omics perspective","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1020","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210564","article-title":"Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer","volume":"219","author":"Masetti","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1025","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1158\/0008-5472.CAN-21-0101","article-title":"Characterizing macrophage diversity in metastasis-bearing lungs reveals a lipid-associated macrophage subset","volume":"81","author":"Huggins","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1030","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000500","article-title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3","author":"Peng","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbcan.2026.189586_bb1035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1040","article-title":"TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1\/BTK axis","volume":"135","author":"Ming","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb1045","article-title":"SPP1(+) macrophages in tumor immunosuppression: mechanisms and therapeutic implications","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.phrs.2019.04.030","article-title":"Osteopontin as a multifaceted driver of bone metastasis and drug resistance","volume":"144","author":"Pang","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ccell.2023.02.004","article-title":"Apolipoprotein e induces pathogenic senescent-like myeloid cells in prostate cancer","volume":"41","author":"Bancaro","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ceb.2009.10.007","article-title":"MTOR and cancer: many loops in one pathway","volume":"22","author":"Efeyan","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1065","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/0008-5472.CAN-23-1489","article-title":"ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis","volume":"84","author":"Shrestha","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1070","article-title":"Nano-strategies targeting cancer-associated fibroblasts to enhance immunotherapy and reverse resistance","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1075","doi-asserted-by":"crossref","first-page":"12357","DOI":"10.1021\/acsnano.9b04857","article-title":"Reshaping prostate tumor microenvironment to suppress metastasis via cancer-associated fibroblast inactivation with peptide-assembly-based nanosystem","volume":"13","author":"Lang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbcan.2026.189586_bb1080","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores t cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb1085","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) t lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1090","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41591-021-01558-5","article-title":"Digital twins for predictive oncology will be a paradigm shift for precision cancer care","volume":"27","author":"Hernandez-Boussard","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.csbj.2022.12.049","article-title":"Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues","volume":"21","author":"Zhang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbcan.2026.189586_bb1100","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189586_bb1105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbrc.2023.04.018","article-title":"DC101, an anti-VEGFR2 agent, promotes high-endothelial venule formation and immune infiltration versus SAR131675 and fruquintinib","volume":"661","author":"Wang","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb1110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161913","article-title":"Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation","volume":"133","author":"Cui","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb1120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb1125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2022.0491","article-title":"Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment","volume":"20","author":"Zhu","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1130","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbae016","article-title":"Cancer cell response to extrinsic and intrinsic mechanical cue: opportunities for tumor apoptosis strategies","volume":"11","author":"Shu","year":"2024","journal-title":"Regener. Biomater."},{"key":"10.1016\/j.bbcan.2026.189586_bb1135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133160","article-title":"Identification of cancer-associated fibroblasts subtypes in prostate cancer","volume":"14","author":"Pan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1412337","article-title":"Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression","volume":"12","author":"Chen","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1145","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/2211-5463.13923","article-title":"Understanding and measuring mechanical signals in the tumor stroma","volume":"15","author":"de la Jara Ortiz","year":"2025","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbcan.2026.189586_bb1150","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3892\/ol.2016.5118","article-title":"Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer","volume":"12","author":"Zheng","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189586_bb1155","article-title":"Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1160","article-title":"CXCL12\/CXCR4 axis governs treg spatial dominance over CD8+ t cells via IL-2 sequestration: a dual therapeutic target in prostate cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862416","article-title":"Myeloid-derived suppressor cells as key players and promising therapy targets in prostate cancer","volume":"12","author":"Siemi\u0144ska","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1012173","article-title":"The role of YAP1 in survival prediction, immune modulation, and drug response: a pan-cancer perspective","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.668349","article-title":"CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion","volume":"11","author":"Gunaydin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00018-022-04455-3","article-title":"Effect of chronic stress on tumorigenesis and development","volume":"79","author":"Wang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1185","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/mc.22468","article-title":"Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells","volume":"55","author":"Wen","year":"2016","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbcan.2026.189586_bb1190","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.7150\/ijbs.101039","article-title":"Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1195","article-title":"Ferroptosis in cancer and inflammatory diseases: mechanisms and therapeutic implications","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1200","doi-asserted-by":"crossref","DOI":"10.4110\/in.2025.25.e6","article-title":"Regulation of ferroptosis in cancer and immune cells","volume":"25","author":"Jang","year":"2025","journal-title":"Immune Netw."},{"key":"10.1016\/j.bbcan.2026.189586_bb1205","article-title":"Ectopic FGFR1 increases intracellular pool of cholesterol in prostate cancer cells","volume":"27","author":"Liu","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031585","article-title":"Prostate cancer-associated fibroblasts: a review on CAF functions, heterogeneity, resistance mechanisms, and future in a chip","volume":"27","author":"Lupsa","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1215","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.21037\/tau-24-127","article-title":"Silencing SPP1 in m2 macrophages inhibits the progression of castration-resistant prostate cancer via the MMP9\/TGF\u03b21 axis","volume":"13","author":"Chen","year":"2024","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1220","article-title":"SPP1+ macrophages and the orchestration of spatially organized immunosuppression in cancer","volume":"14","author":"Li","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbcan.2026.189586_bb1225","article-title":"Intercellular communication between FAP+ fibroblasts and SPP1+ macrophages in prostate cancer via multi-omics","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1158\/2159-8290.CD-23-0397","article-title":"Nerves at play: the peripheral nervous system in extracranial malignancies","volume":"15","author":"Vermeer","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb1235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.35772\/ghmo.2023.01021","article-title":"The role of endocrine gland derived vascular growth factor\/ prokineticin-1 in human prostate cells","volume":"4","author":"Sinisi","year":"2024","journal-title":"GHM Open"},{"key":"10.1016\/j.bbcan.2026.189586_bb1240","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s00018-011-0664-z","article-title":"Neurexins and neuroligins: synapses look out of the nervous system","volume":"68","author":"Bottos","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1245","article-title":"Mitochondrial transfer between cancer and t cells: implications for immune evasion","volume":"14","author":"Chun","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1250","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1007\/s00018-017-2578-x","article-title":"How Schwann cells facilitate cancer progression in nerves","volume":"74","author":"Deborde","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218070","article-title":"The neuro-immune oncology axis","volume":"634","author":"Vanden Abeele","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189586_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217090","article-title":"Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer","volume":"598","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189586_bb1265","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1007\/s11357-025-01538-4","article-title":"The prognostic and neuroendocrine implications of SLC25A29-mediated biomass signature in prostate cancer","volume":"47","author":"Wu","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.bbcan.2026.189586_bb1270","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18030359","article-title":"TREM2 in urological malignancies and benign lesions: mechanistic convergence, functional heterogeneity, and translational perspectives: a narrative review","volume":"18","author":"Dai","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1275","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.7150\/ijbs.91519","article-title":"TREM2 promotes macrophage polarization from m1 to m2 and suppresses osteoarthritis through the NF-\u03baB\/CXCL3 axis","volume":"20","author":"Fang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1280","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-24-0060","article-title":"Androgen deprivation therapy drives a distinct immune phenotype in localized prostate cancer","volume":"30","author":"Dallos","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1285","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s43587-025-00842-0","article-title":"Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer","volume":"5","author":"Cheng","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.bbcan.2026.189586_bb1290","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in t cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb1295","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1078-0432.CCR-22-2340","article-title":"Radiotherapy induces innate immune responses in patients treated for prostate cancers","volume":"29","author":"Cheema","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1300","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4049\/jimmunol.2200696","article-title":"Restored thymic output after androgen blockade participates in antitumor immunity","volume":"210","author":"Polesso","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/2159-8290.CD-24-0559","article-title":"Androgen receptor inhibition increases MHC class i expression and improves immune response in prostate cancer","volume":"15","author":"Chesner","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb1310","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/cncr.33397","article-title":"Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: preliminary findings","volume":"127","author":"Hoogland","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1315","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s42003-022-03843-6","article-title":"Reversible epigenetic alterations regulate class i HLA loss in prostate cancer","volume":"5","author":"Rodems","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1320","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1038\/s41467-021-25624-1","article-title":"Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse","volume":"12","author":"Taavitsainen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb1325","first-page":"803","article-title":"Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression","volume":"2","author":"Lopez-Bujanda","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189586_bb1330","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41591-021-01600-6","article-title":"Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial","volume":"28","author":"Powles","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1335","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/intimm\/dxaf037","article-title":"TREX1 exonuclease in immunity and disease","volume":"37","author":"Shang","year":"2025","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1340","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1345","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1350","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000792","article-title":"High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot","volume":"8","author":"Keam","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1355","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1158\/1078-0432.CCR-17-3427","article-title":"Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy","volume":"24","author":"Marciscano","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1360","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1365","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1470-2045(14)70189-5","article-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","volume":"15","author":"Kwon","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1370","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2026.189586_bb1375","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2413732122","article-title":"DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers","volume":"122","author":"Sun","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189586_bb1380","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaoncol.2021.7298","article-title":"Efficacy and safety of autologous dendritic cell-based immunotherapy, docetaxel, and prednisone vs placebo in patients with metastatic castration-resistant prostate cancer: the VIABLE phase 3 randomized clinical trial","volume":"8","author":"Vogelzang","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2022.02.023","article-title":"Pembrolizumab plus docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer: long-term results from the phase 1b\/2 KEYNOTE-365 cohort b study","volume":"82","author":"Yu","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1390","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO-24-01283","article-title":"Pembrolizumab plus docetaxel versus docetaxel for previously treated metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-921 trial","volume":"43","author":"Petrylak","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1395","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050773","article-title":"Tumor-associated macrophage promotes the survival of cancer cells upon docetaxel chemotherapy via the CSF1\/CSF1R-CXCL12\/CXCR4 axis in castration-resistant prostate cancer","volume":"12","author":"Guan","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1400","doi-asserted-by":"crossref","first-page":"68650","DOI":"10.18632\/oncotarget.11896","article-title":"Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction","volume":"7","author":"Mathew","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189586_bb1405","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071755","article-title":"Roles of NK cell receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in cancer","volume":"12","author":"Buller","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1410","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.annonc.2020.09.012","article-title":"Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study","volume":"31","author":"Giannatempo","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1415","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/fon.13.270","article-title":"The potential detrimental effect of corticosteroids in prostate cancer","volume":"10","author":"Rescigno","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1420","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.juro.2008.11.121","article-title":"Phase II trial of neoadjuvant nab-paclitaxel in high risk patients with prostate cancer undergoing radical prostatectomy","volume":"181","author":"Shepard","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1425","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm.4308","article-title":"VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer","volume":"23","author":"Gao","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1430","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccell.2020.08.007","article-title":"Nivolumab plus ipilimumab for metastatic castration-resistant prostate cancer: preliminary analysis of patients in the CheckMate 650 trial","volume":"38","author":"Sharma","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768957","article-title":"Mechanisms of immune checkpoint inhibitor-mediated colitis","volume":"12","author":"Westdorp","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1440","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb1445","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","article-title":"Molecular pathways of colon inflammation induced by cancer immunotherapy","volume":"182","author":"Luoma","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1450","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1158\/2326-6066.CIR-19-0371","article-title":"Enzalutamide, an androgen receptor antagonist, enhances myeloid cell-mediated immune suppression and tumor progression","volume":"8","author":"Consiglio","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1455","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41586-018-0266-0","article-title":"IL-23 secreted by myeloid cells drives castration-resistant prostate cancer","volume":"559","author":"Calcinotto","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb1460","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/pcan.2015.39","article-title":"Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance","volume":"18","author":"Martin","year":"2015","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bbcan.2026.189586_bb1465","doi-asserted-by":"crossref","first-page":"234","DOI":"10.18632\/oncotarget.2703","article-title":"PD-L1 is highly expressed in enzalutamide resistant prostate cancer","volume":"6","author":"Bishop","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189586_bb1470","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006581","article-title":"Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109674","article-title":"Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis","volume":"27","author":"Xiong","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2026.189586_bb1480","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/bjc.2017.451","article-title":"WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages","volume":"118","author":"Lee","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1485","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1541-7786.MCR-24-0791","article-title":"Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis","volume":"23","author":"Mei","year":"2025","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1490","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1495","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/JCO.19.01638","article-title":"Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1500","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/pcan.2016.49","article-title":"Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis","volume":"20","author":"Benzon","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bbcan.2026.189586_bb1505","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb1510","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-Seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1515","doi-asserted-by":"crossref","first-page":"53","DOI":"10.36401\/JIPO-23-18","article-title":"B7-H3 inhibitors in oncology clinical trials: a review","volume":"7","author":"Feustel","year":"2024","journal-title":"J. Immunother. Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1520","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0274","article-title":"Systems-level liquid biopsy in advanced prostate cancer","volume":"32","author":"Lyman","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1525","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-15-2428","article-title":"Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy","volume":"22","author":"Picarda","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1530","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1158\/1535-7163.MCT-21-0554","article-title":"DS-7300a, a DNA topoisomerase i inhibitor, DXd-based antibody-drug conjugate targeting B7-H3, exerts potent antitumor activities in preclinical models","volume":"21","author":"Yamato","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189586_bb1535","article-title":"690P ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: updated clinical and biomarker results from a phase I\/II study","volume":"34","author":"Patel","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1540","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007174","article-title":"Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma","volume":"11","author":"Brignole","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1545","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2018.01.012","article-title":"SLFN11 blocks stressed replication forks independently of ATR","volume":"69","author":"Murai","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243379","article-title":"Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer","volume":"15","author":"Azuma","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189586_bb1555","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41698-025-01131-0","article-title":"The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer","volume":"9","author":"Lin","year":"2025","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1560","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/2159-8290.CD-23-0964","article-title":"Xaluritamig, a STEAP1 \u00d7 CD3 XmAb 2+1 immune therapy for metastatic castration-resistant prostate cancer: results from dose exploration in a first-in-human study","volume":"14","author":"Kelly","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb1565","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020606118","article-title":"Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches","volume":"118","author":"Chang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189586_bb1570","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02820-2","article-title":"The expression, regulation, and function of human endogenous retroviruses in genitourinary cancers","volume":"11","author":"Ma","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189586_bb1575","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1580","article-title":"RNA epigenetics in cancer: current knowledge and therapeutic implications","volume":"6","author":"Huang","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1585","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13046-025-03294-x","article-title":"Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition","volume":"44","author":"Jakobsen","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1590","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7150\/ijbs.103877","article-title":"Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy","volume":"21","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2026.189586_bb1595","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1158\/2767-9764.CRC-21-0139","article-title":"Potent stimulation of the androgen receptor instigates a viral mimicry response in prostate cancer","volume":"2","author":"Alizadeh-Ghodsi","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189586_bb1600","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190928","article-title":"Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models","volume":"136","author":"Li","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb1605","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk4423","article-title":"Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT: AP-1 signaling","volume":"10","author":"Chomiak","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189586_bb1610","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-23-2742","article-title":"Ketogenic diet alters the epigenetic and immune landscape of prostate cancer to overcome resistance to immune checkpoint blockade therapy","volume":"84","author":"Murphy","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1615","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020462","article-title":"Decitabine augments chemotherapy-induced PD-L1 upregulation for PD-L1 blockade in colorectal cancer","volume":"12","author":"Huang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1620","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020294","article-title":"It takes two to tango: the interplay between prostate cancer and its microenvironment from an epigenetic perspective","volume":"16","author":"Zaalberg","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1625","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.742561","article-title":"Emerging advances in combinatorial treatments of epigenetically altered pediatric high-grade H3K27M gliomas","volume":"12","author":"Leszczynska","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2026.189586_bb1630","doi-asserted-by":"crossref","DOI":"10.1186\/s13100-025-00383-8","article-title":"Endogenous retroviruses in aging and cancer: from genomic defense to oncogenic activation","volume":"16","author":"Arantes Dos Santos","year":"2025","journal-title":"Mob. DNA"},{"key":"10.1016\/j.bbcan.2026.189586_bb1635","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051145","article-title":"Novel combinatorial approaches to tackle the immunosuppressive microenvironment of prostate cancer","volume":"13","author":"Shackleton","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1640","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030358","article-title":"ADRB2-targeting therapies for prostate cancer","volume":"11","author":"Kulik","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1645","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12967-025-06644-7","article-title":"Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis","volume":"23","author":"Thulin","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1650","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.3390\/curroncol29110642","article-title":"CD36 and its role in regulating the tumor microenvironment","volume":"29","author":"Liao","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1655","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2026.189586_bb1660","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1913791","article-title":"Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy","volume":"13","author":"Waldhauer","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/j.bbcan.2026.189586_bb1665","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071887","article-title":"The role of cancer-associated fibroblasts in prostate cancer tumorigenesis","volume":"12","author":"Bonollo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189586_bb1670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105374","article-title":"Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and\/or metastatic cervical squamous cell carcinoma","volume":"109","author":"Verlingue","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2026.189586_bb1675","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1158\/1078-0432.CCR-20-1358","article-title":"Imaging fibroblast activation protein alpha improves diagnosis of metastatic prostate cancer with positron emission tomography","volume":"26","author":"Hintz","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189586_bb1680","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2026.189586_bb1685","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1690","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede t-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb1695","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1700","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/acel.12571","article-title":"Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-\u03baB-dependent mechanism","volume":"16","author":"Flores","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1705","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","article-title":"Mechanisms underlying t cell ageing","volume":"19","author":"Goronzy","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1710","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1073\/pnas.1409155111","article-title":"Diversity and clonal selection in the human T-cell repertoire","volume":"111","author":"Qi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189586_bb1715","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific t cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1720","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189586_bb1725","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on t cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1730","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189586_bb1735","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02404-x","article-title":"Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"18","author":"An","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189586_bb1740","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3389\/fimmu.2019.01940","article-title":"The obesity paradox in cancer, tumor immunology, and immunotherapy: potential therapeutic implications in triple negative breast cancer","volume":"10","author":"Naik","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1745","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory t cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189586_bb1750","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb1755","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","article-title":"Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8(+) t cells","volume":"51","author":"Bachem","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2026.189586_bb1760","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb1765","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jamaoncol.2019.2785","article-title":"Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer","volume":"5","author":"Pinato","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1770","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb1775","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","article-title":"Spatial omics and multiplexed imaging to explore cancer biology","volume":"18","author":"Lewis","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbcan.2026.189586_bb1780","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","article-title":"Method of the year: spatially resolved transcriptomics","volume":"18","author":"Marx","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbcan.2026.189586_bb1785","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","article-title":"Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images","volume":"23","author":"Saltz","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189586_bb1790","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of t cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189586_bb1795","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb1800","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189586_bb1805","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","article-title":"Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: a systematic review and meta-analysis","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbcan.2026.189586_bb1810","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189586_bb1815","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev-biophys-042910-155238","article-title":"Receptor signaling clusters in the immune synapse","volume":"41","author":"Dustin","year":"2012","journal-title":"Annu. Rev. Biophys."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:43:40Z","timestamp":1780605820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":363,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0304419X26000582"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189586","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189586"}}